Mucins: a biologically relevant glycan barrier in mucosal protection.

BACKGROUND The mucins found as components of mucus gel layers at mucosal surfaces throughout the body play roles in protection as part of the defensive barrier on an organ and tissue specific basis. SCOPE OF THE REVIEW The human MUC gene family codes up to 20 known proteins, which can be divided into secreted and membrane-associated forms each with a typical protein domain structure. The secreted mucins are adapted to cross link in order to allow formation of the extended mucin networks found in the secreted mucus gels. The membrane-associated mucins possess membrane specific domains which enable their various biological functions as part of the glycocalyx. All mucins are highly O-glycosylated and this is tissue specific and linked with specific biological functions at these locations. Mucin biology is dynamic and the processes of degradation and turnover are well integrated with biosynthesis to maintain a continuous mucosal protection against all external aggressive forces. Interaction of mucins with microflora plays an important role in normal function. Mucins are modified in a variety of diseases and this may be due to abberant mucin peptide or glycosylation. MAJOR CONCLUSIONS Mucins represent a family of glycoprotein having fundamental roles in mucosal protection and communication with external environment. GENERAL SIGNIFICANCE The review emphasises the nature of mucins as glycoproteins and their role in presenting an array of glycan structures at the mucosal cell surface.

[1]  T. Hennet Diseases of glycosylation beyond classical congenital disorders of glycosylation. , 2012, Biochimica et biophysica acta.

[2]  R. Kannagi,et al.  Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells , 1998, Journal of surgical oncology.

[3]  T. Irimura,et al.  Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma , 2003, Histopathology.

[4]  S. Baldus,et al.  Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope. , 2005, International journal of oncology.

[5]  G. Hansson,et al.  The human MUC2 mucin apoprotein appears to dimerize before O-glycosylation and shares epitopes with the 'insoluble' mucin of rat small intestine. , 1995, The Biochemical journal.

[6]  Henrik Clausen,et al.  Mucin-type O-glycosylation and its potential use in drug and vaccine development. , 2008, Biochimica et biophysica acta.

[7]  Brandi L. Cantarel,et al.  Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease , 2012, PloS one.

[8]  R. Ley,et al.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes , 2008, Nature.

[9]  J. Braun,et al.  Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. , 2011, The Journal of clinical investigation.

[10]  Jeffrey I. Gordon,et al.  A rendezvous with our microbes , 2011, Proceedings of the National Academy of Sciences.

[11]  S. Kudoh,et al.  Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis , 2011, Human Genetics.

[12]  B. Henrissat,et al.  Carbohydrate-active enzymes from pigmented Bacilli: a genomic approach to assess carbohydrate utilization and degradation , 2011, BMC Microbiology.

[13]  J. Marth,et al.  Glycosylation in Cellular Mechanisms of Health and Disease , 2006, Cell.

[14]  Judy M. Anderson,et al.  Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer , 2013, Clinical Cancer Research.

[15]  L. Hoskins,et al.  Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. , 1985, The Journal of clinical investigation.

[16]  S. Randell,et al.  C-Mannosylation of MUC5AC and MUC5B Cys subdomains. , 2004, Glycobiology.

[17]  A. Hölscher,et al.  Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma , 2002, Annals of Surgical Oncology.

[18]  L. Hoskins Mucin degradation in the human gastrointestinal tract and its significance to enteric microbial ecology , 1993 .

[19]  Lawrence A Tabak,et al.  All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.

[20]  G. Hansson,et al.  Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[21]  V. Nizet,et al.  Innovations in host and microbial sialic acid biosynthesis revealed by phylogenomic prediction of nonulosonic acid structure , 2009, Proceedings of the National Academy of Sciences.

[22]  The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma , 2012, Clinical & Experimental Metastasis.

[23]  M. Johansson,et al.  Altered O‐glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation , 2011, Inflammatory bowel diseases.

[24]  N. Smorodinsky,et al.  Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies. , 1996, Biochemical and biophysical research communications.

[25]  C. A. Carraway,et al.  Muc4/Sialomucin Complex in the Mammary Gland and Breast Cancer , 2001, Journal of Mammary Gland Biology and Neoplasia.

[26]  C. Kelly,et al.  Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses. , 2013, Journal of medical microbiology.

[27]  D. Breuillé,et al.  Development of a rapid and convenient method to purify mucins and determine their in vivo synthesis rate in rats. , 2002, Analytical biochemistry.

[28]  Bharat Bhushan,et al.  Bioadhesion: a review of concepts and applications , 2012, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[29]  H. Flint,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[30]  J. Gordon,et al.  Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity. , 2001, Glycobiology.

[31]  M. Fukuda Possible roles of tumor-associated carbohydrate antigens. , 1996, Cancer research.

[32]  J. Pearson,et al.  Upper Airway Mucin Gene Expression: A Review , 2007, The Laryngoscope.

[33]  G. Macfarlane,et al.  Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. , 1993, Gut.

[34]  I. van Seuningen,et al.  The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers. , 2010, Biochimie.

[35]  Pauline M. Rudd,et al.  High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations* , 2011, Molecular & Cellular Proteomics.

[36]  M. Johansson,et al.  The gastrointestinal mucus system in health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[37]  Reen Wu,et al.  Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. , 2004, American journal of respiratory cell and molecular biology.

[38]  N. Alexis,et al.  Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways? , 2008, American journal of physiology. Lung cellular and molecular physiology.

[39]  Benjamin P. Westover,et al.  Glycan Foraging in Vivo by an Intestine-Adapted Bacterial Symbiont , 2005, Science.

[40]  Carolyn R Bertozzi,et al.  Synthetic glycobiology: Exploits in the Golgi compartment. , 2006, Current opinion in chemical biology.

[41]  I. Gipson,et al.  Assessing mucin expression and function in human ocular surface epithelia in vivo and in vitro. , 2012, Methods in molecular biology.

[42]  S. S. Olmsted,et al.  Glycosidase and Proteinase Activity of Anaerobic Gram-Negative Bacteria Isolated From Women With Bacterial Vaginosis , 2003, Sexually transmitted diseases.

[43]  K. Carraway,et al.  Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. , 2007, Current topics in developmental biology.

[44]  David A. Mills,et al.  The Human Gut Microbiota and Undernutrition , 2012, Science Translational Medicine.

[45]  M. Icaza-Chávez Gut microbiota in health and disease , 2013 .

[46]  M. McGuckin,et al.  Mucin Dynamics in Intestinal Bacterial Infection , 2008, PloS one.

[47]  Y. Hiki,et al.  Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients. , 2002, Journal of nephrology.

[48]  R. Kannagi Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer , 1997, Glycoconjugate Journal.

[49]  G. Gibson,et al.  Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. , 1993, The Journal of applied bacteriology.

[50]  M Garrido,et al.  MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. , 1995, Gastroenterology.

[51]  J. Michalski,et al.  Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. , 2004, The Biochemical journal.

[52]  G. Hansson,et al.  A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. , 2009, Glycobiology.

[53]  L. Tabak,et al.  The Lectin Domain of the Polypeptide GalNAc Transferase Family of Glycosyltransferases (ppGalNAc Ts) Acts as a Switch Directing Glycopeptide Substrate Glycosylation in an N- or C-terminal Direction, Further Controlling Mucin Type O-Glycosylation* , 2013, The Journal of Biological Chemistry.

[54]  H. Wandall,et al.  Loss of a novel mucin-like epithelial glycoprotein in oral and cervical squamous cell carcinomas. , 1997, Cancer research.

[55]  M. Pasdar,et al.  The importance of MUC1 cellular localization in patients with breast carcinoma , 2001, Cancer.

[56]  I. van Seuningen,et al.  Mucins and Pancreatic Cancer , 2010, Cancers.

[57]  Ronn S. Friedlander,et al.  Mucin Biopolymers Prevent Bacterial Aggregation by Retaining Cells in the Free-Swimming State , 2012, Current Biology.

[58]  Ron A Wevers,et al.  Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. , 2006, Clinical chemistry.

[59]  V. Gouyer,et al.  Architecture of the large membrane-bound mucins. , 2008, Gene.

[60]  J. Desseyn Mucin CYS domains are ancient and highly conserved modules that evolved in concert. , 2009, Molecular phylogenetics and evolution.

[61]  A. Corfield,et al.  The roles of enteric bacterial sialidase, sialateO-acetyl esterase and glycosulfatase in the degradation of human colonic mucin , 1993, Glycoconjugate Journal.

[62]  C. Collins,et al.  Differential glycosylation of polymeric and monomeric IgM. , 1989, Molecular immunology.

[63]  J. Sobel,et al.  The vaginal microbiome: new information about genital tract flora using molecular based techniques , 2011, BJOG : an international journal of obstetrics and gynaecology.

[64]  L. Xia,et al.  Core 3-derived O-glycans are essential for intestinal mucus barrier function. , 2010, Methods in enzymology.

[65]  A. Varki Sialic acids in human health and disease. , 2008, Trends in molecular medicine.

[66]  P. Quinton,et al.  Mucociliary transport in porcine trachea: differential effects of inhibiting chloride and bicarbonate secretion. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[67]  N. Cameron,et al.  A spoonful of sugar: the application of glycopolymers in therapeutics , 2011 .

[68]  M. Johansson,et al.  An ex vivo method for studying mucus formation , properties , and thickness in human colonic biopsies and mouse small and large intestinal explants , 2012 .

[69]  D. Swallow,et al.  Mucin methods: genes encoding mucins and their genetic variation with a focus on gel-forming mucins. , 2012, Methods in molecular biology.

[70]  F. dall’Olio,et al.  UDP-Ga1NAc:NeuAcα2,3Galβ-R (GaINAc to Gal) β1,4-N-acetyl-galactosaminyltransferase responsible for the Sda specificity in human colon carcinoma CaCo-2 cell line , 1991 .

[71]  V. Tremaroli,et al.  Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88 , 2011, Gut.

[72]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[73]  Mary Frances Picciano,et al.  Human Nutrition , 1994 .

[74]  J. Lüttges,et al.  The Mucin Profile of Noninvasive and Invasive Mucinous Cystic Neoplasms of the Pancreas , 2002, The American journal of surgical pathology.

[75]  T.W.T. Dillon,et al.  What Is a Complex , 1943 .

[76]  R. Lloubès,et al.  Molecular Cloning of the Oncofetal Isoform of the Human Pancreatic Bile Salt-dependent Lipase* , 1998, The Journal of Biological Chemistry.

[77]  M. Hollingsworth,et al.  Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism. , 2005, Glycobiology.

[78]  B. Warren,et al.  Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence , 1999, Glycoconjugate Journal.

[79]  T. Okada,et al.  Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[80]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[81]  Richard D. Cummings,et al.  The repertoire of glycan determinants in the human glycome. , 2009, Molecular bioSystems.

[82]  H. Cooper,et al.  Determination of Aberrant O-Glycosylation in the IgA1 Hinge Region by Electron Capture Dissociation Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry* , 2005, Journal of Biological Chemistry.

[83]  T. Samuelsson,et al.  Gel-forming mucins appeared early in metazoan evolution , 2007, Proceedings of the National Academy of Sciences.

[84]  R. Ramphal,et al.  Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa. , 1993, American journal of respiratory cell and molecular biology.

[85]  R. Dahiya,et al.  Heterogeneity of mucin gene expression in normal and neoplastic tissues. , 1993, Cancer research.

[86]  I. Brockhausen,et al.  Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.

[87]  D. Taylor-Robinson,et al.  A longitudinal study of bacterial vaginosis during pregnancy , 1994, British journal of obstetrics and gynaecology.

[88]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[89]  N. Adsay,et al.  Role of MUC Genes and Mucins in Pancreatic Neoplasia , 2006, The American Journal of Gastroenterology.

[90]  S. Baldus,et al.  Histopathological Subtypes and Prognosis of Gastric Cancer Are Correlated with the Expression of Mucin-Associated Sialylated Antigens: Sialosyl-Lewisa, Sialosyl-Lewisx and Sialosyl-Tn , 1998, Tumor Biology.

[91]  A. Corfield,et al.  Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria , 1992, Infection and immunity.

[92]  M. Bäckström,et al.  Composition and functional role of the mucus layers in the intestine , 2011, Cellular and Molecular Life Sciences.

[93]  Jeffrey I. Gordon,et al.  Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.

[94]  F. Bäckhed,et al.  Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling , 2012, Nature.

[95]  A. M. Roberton,et al.  A Novel Bacterial Mucinase, Glycosulfatase, Is Associated with Bacterial Vaginosis , 2005, Journal of Clinical Microbiology.

[96]  I. Brockhausen,et al.  O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. , 1994, European journal of biochemistry.

[97]  M. Johansson,et al.  Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein. , 2009, Journal of proteome research.

[98]  Brandi L. Cantarel,et al.  The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics , 2008, Nucleic Acids Res..

[99]  L C Hoskins,et al.  Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes. , 1981, The Journal of clinical investigation.

[100]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[101]  J. Gordon,et al.  A Model of Host-Microbial Interactions in an Open Mammalian Ecosystem , 1996, Science.

[102]  Dave Singh,et al.  MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[103]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[104]  S. Buus,et al.  Cancer Associated Aberrant Protein O-Glycosylation Can Modify Antigen Processing and Immune Response , 2012, PloS one.

[105]  M. Barber,et al.  Diversity , 2010, The Fairchild Books Dictionary of Fashion.

[106]  J. Walter,et al.  Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm , 2010, Proceedings of the National Academy of Sciences.

[107]  Ronan Gough,et al.  Construction of a natural mucin microarray and interrogation for biologically relevant glyco-epitopes. , 2012, Analytical chemistry.

[108]  I. Gipson,et al.  Membrane-tethered mucins have multiple functions on the ocular surface. , 2010, Experimental eye research.

[109]  R. Knight,et al.  Diversity, stability and resilience of the human gut microbiota , 2012, Nature.

[110]  L. T. Angenent,et al.  Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? , 2004, Nature Immunology.

[111]  Haike Ghazarian,et al.  A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. , 2011, Acta histochemica.

[112]  Hirofumi Takeuchi,et al.  Study on the mucoadhesion mechanism of pectin by atomic force microscopy and mucin-particle method , 2010 .

[113]  J. Lo-Guidice,et al.  Human airway mucin glycosylation: A combinatory of carbohydrate determinants which vary in cystic fibrosis , 2001, Glycoconjugate Journal.

[114]  Thomas P. Clausen,et al.  A high-throughput O-glycopeptide discovery platform for seromic profiling. , 2010, Journal of proteome research.

[115]  F. Theissig,et al.  Comparative study of the intestinal mucus barrier in normal and inflamed colon , 2006, Gut.

[116]  Jan Mollenhauer,et al.  DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours , 1997, Nature Genetics.

[117]  J. Fléjou,et al.  Abnormal Expression of Gastric Mucin in Human and Rat Aberrant Crypt Foci during Colon Carcinogenesis , 2003, Tumor Biology.

[118]  V. Korolik,et al.  Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.

[119]  V. Khutoryanskiy Advances in mucoadhesion and mucoadhesive polymers. , 2011, Macromolecular bioscience.

[120]  G. Lauc,et al.  Protein glycosylation--an evolutionary crossroad between genes and environment. , 2010, Molecular bioSystems.

[121]  R. Knight,et al.  Bacterial Community Variation in Human Body Habitats Across Space and Time , 2009, Science.

[122]  M. Copin,et al.  Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. , 1996, Gastroenterology.

[123]  M. Johansson,et al.  An Autocatalytic Cleavage in the C Terminus of the Human MUC2 Mucin Occurs at the Low pH of the Late Secretory Pathway* , 2003, The Journal of Biological Chemistry.

[124]  G. Uccello-Barretta,et al.  A nuclear magnetic resonance approach to the comparison of mucoadhesive properties of polysaccharides for ophthalmic uses. , 2011, International journal of pharmaceutics.

[125]  N. Smorodinsky,et al.  A Novel Protein Derived from the MUC1 Gene by Alternative Splicing and Frameshifting* , 2005, Journal of Biological Chemistry.

[126]  N. Smorodinsky,et al.  The MUC1 SEA Module Is a Self-cleaving Domain* , 2005, Journal of Biological Chemistry.

[127]  J. Sheehan,et al.  Analyzing the functions of large glycoconjugates through the dissipative properties of their absorbed layers using the gel-forming mucin MUC5B as an example. , 2008, Glycobiology.

[128]  N. Juge,et al.  Microbial adhesins to gastrointestinal mucus. , 2012, Trends in microbiology.

[129]  M. Millar,et al.  Application of a novel human cervical mucin-based assay demonstrates the absence of increased mucinase activity in bacterial vaginosis , 2002, International journal of STD & AIDS.

[130]  Kelly G Ten Hagen,et al.  Mucin-type O-Glycosylation during Development* , 2013, The Journal of Biological Chemistry.

[131]  L. Hoskins,et al.  Degradation of blood group antigens in human colon ecosystems. I. In vitro production of ABH blood group-degrading enzymes by enteric bacteria. , 1976, The Journal of clinical investigation.

[132]  Harry J Flint,et al.  The impact of nutrition on the human microbiome. , 2012, Nutrition reviews.

[133]  Sylvain Julien,et al.  Tumour-associated carbohydrate antigens in breast cancer , 2010, Breast Cancer Research.

[134]  J. Cameron,et al.  MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. , 2002, American journal of clinical pathology.

[135]  R. Dwek,et al.  The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor Interactions* , 1998, The Journal of Biological Chemistry.

[136]  Pauline M Rudd,et al.  Glycans as cancer biomarkers. , 2012, Biochimica et biophysica acta.

[137]  C. Probert,et al.  Mucins in the gastrointestinal tract in health and disease. , 2001, Frontiers in bioscience : a journal and virtual library.

[138]  N. Toribara,et al.  The Adherent Gastric Mucous Layer Is Composed of Alternating Layers of MUC5AC and MUC6 Mucin Proteins , 2004, Digestive Diseases and Sciences.

[139]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[140]  J. Gordon,et al.  Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. , 2008, Cell host & microbe.

[141]  M. Kleerebezem,et al.  Comparative analysis of proteins with a mucus-binding domain found exclusively in lactic acid bacteria. , 2006, Microbiology.

[142]  Abdul W Basit,et al.  An investigation into the role of mucus thickness on mucoadhesion in the gastrointestinal tract of pig. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[143]  P. Quinton Role of epithelial HCO3⁻ transport in mucin secretion: lessons from cystic fibrosis. , 2010, American journal of physiology. Cell physiology.

[144]  A. J. Macpherson,et al.  Layers of mutualism with commensal bacteria protect us from intestinal inflammation , 2006, Gut.

[145]  S. Gendler,et al.  Structure and function of the cell surface (tethered) mucins. , 2008, Annual review of physiology.

[146]  R. Carrier,et al.  Barrier properties of gastrointestinal mucus to nanoparticle transport. , 2010, Macromolecular bioscience.

[147]  J. Irwin,et al.  Analysing mucin degradation. , 2012, Methods in molecular biology.

[148]  D. Relman,et al.  Assembly of the human intestinal microbiota. , 2006, Trends in ecology & evolution.

[149]  A. Dell,et al.  Mucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression. , 2005, American journal of respiratory cell and molecular biology.

[150]  J. Gordon,et al.  Honor Thy Gut Symbionts Redux , 2012, Science.

[151]  P. Gosset,et al.  Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori. , 2012, Glycobiology.

[152]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[153]  I. Banerjee,et al.  Self‐Assembly and Growth of Smart Cell‐Adhesive Mucin‐Bound Microtubes , 2009 .

[154]  P. Delmotte,et al.  Sialyl-Lex and sulfo-sialyl-Lex determinants are receptors for P. aeruginosa , 2000, Glycoconjugate Journal.

[155]  J. Gordon,et al.  Homeostasis and Inflammation in the Intestine , 2010, Cell.

[156]  R. Miller,et al.  Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a "most probable number" method. , 1981, Gastroenterology.

[157]  S. Hakomori,et al.  Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients , 1990, Cancer.

[158]  M. McGuckin,et al.  Structure and function of the polymeric mucins in airways mucus. , 2008, Annual review of physiology.

[159]  D. Burton,et al.  Glycosylation: disease targets and therapy. , 2005, Advances in experimental medicine and biology.

[160]  R. Knight,et al.  Moving pictures of the human microbiome , 2011, Genome Biology.

[161]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[162]  Yin Chen,et al.  Cloning and characterization of human MUC19 gene. , 2011, American journal of respiratory cell and molecular biology.

[163]  P. Malfertheiner,et al.  Helicobacter pylori and Other Gastric Bacteria , 2011, Digestive Diseases.

[164]  N. Docherty,et al.  Sulphate‐reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis , 2009, The British journal of surgery.

[165]  N. Corcionivoschi,et al.  Defense and Adaptation: The Complex Inter-Relationship between Campylobacter jejuni and Mucus , 2012, Front. Cell. Inf. Microbio..

[166]  L. Holm,et al.  The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[167]  P. Gagneux,et al.  Glycan Evolution in Response to Collaboration, Conflict, and Constraint* , 2013, The Journal of Biological Chemistry.

[168]  O. N. Oliveira,et al.  Interaction of chitosan and mucin in a biomembrane model environment. , 2012, Journal of colloid and interface science.

[169]  A. Corfield,et al.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease , 2000, Gut.

[170]  L. T. Angenent,et al.  Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy , 2012, Cell.

[171]  S. Batra,et al.  Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. , 2006, Biochimica et biophysica acta.

[172]  J. Gordon,et al.  Human nutrition, the gut microbiome and the immune system , 2011, Nature.

[173]  I. Brockhausen 3.03 – Biosynthesis of Mucin-Type O-Glycans , 2007 .

[174]  K. Carraway,et al.  Molecular signaling in the regulation of mucins , 2007, Journal of cellular biochemistry.

[175]  A. Varki,et al.  Chemical Diversity in the Sialic Acids and Related α‐Keto Acids: An Evolutionary Perspective , 2010 .

[176]  Jeffrey I. Gordon,et al.  Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[177]  M. Johansson,et al.  The gastric mucus layers: constituents and regulation of accumulation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[178]  T. Hardingham,et al.  Concentrated solutions of salivary MUC5B mucin do not replicate the gel-forming properties of saliva. , 2002, The Biochemical journal.

[179]  D. Banji,et al.  Mucoadhesive drug delivery system: An overview , 2010, Journal of advanced pharmaceutical technology & research.

[180]  G. Huffnagle,et al.  Does the microbiota regulate immune responses outside the gut? , 2004, Trends in microbiology.

[181]  V. Gouyer,et al.  Involvement of glycosylation in the intracellular trafficking of glycoproteins in polarized epithelial cells. , 2003, Biochimie.

[182]  K. Abbott,et al.  Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers. , 2010, Methods in enzymology.

[183]  Daniel B. DiGiulio,et al.  Development of the Human Infant Intestinal Microbiota , 2007, PLoS biology.

[184]  Lena Holm,et al.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria , 2010, Gut microbes.

[185]  I. Brockhausen,et al.  The Relative Activities of the C2GnT1 and ST3Gal-I Glycosyltransferases Determine O-Glycan Structure and Expression of a Tumor-associated Epitope on MUC1* , 2001, The Journal of Biological Chemistry.

[186]  J. Griffith,et al.  Unpacking a gel-forming mucin: a view of MUC5B organization after granular release. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[187]  P. Delannoy,et al.  Consequences of the expression of sialylated antigens in breast cancer. , 2010, Carbohydrate research.

[188]  P. Turnbaugh,et al.  The core gut microbiome, energy balance and obesity , 2009, The Journal of physiology.

[189]  J. Gordon,et al.  Honor thy symbionts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[190]  S. Batra,et al.  Current status of mucins in the diagnosis and therapy of cancer , 2009, BioFactors.

[191]  R. Brossmer,et al.  Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells , 2005, Glycoconjugate Journal.

[192]  D. Santini,et al.  Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. , 2007, Glycobiology.

[193]  C. Bertozzi,et al.  Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.

[194]  J. Nesland,et al.  Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases. , 1992, APMIS. Supplementum.

[195]  A. Hölscher,et al.  Immunoreactivity of Monoclonal Antibody BW835 Represents a Marker of Progression and Prognosis in Early Gastric Cancer , 2001, Oncology.

[196]  L. Hoskins,et al.  Mucin degradation in human colon ecosystems. Degradation of hog gastric mucin by fecal extracts and fecal cultures. , 1981, Gastroenterology.

[197]  J. Lafitte,et al.  The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. , 1999, Glycobiology.

[198]  S. Gordon,et al.  Generation of ligand‐receptor alliances by “SEA” module‐mediated cleavage of membrane‐associated mucin proteins , 2002, Protein science : a publication of the Protein Society.

[199]  Mirian Ueno,et al.  Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice , 2011, PLoS biology.

[200]  Bernard Henrissat,et al.  The abundance and variety of carbohydrate-active enzymes in the human gut microbiota , 2013, Nature Reviews Microbiology.

[201]  D. Thornton,et al.  Identification of Molecular Intermediates in the Assembly Pathway of the MUC5AC Mucin* , 2004, Journal of Biological Chemistry.

[202]  N. Rigby,et al.  Lamellar structures of MUC2-rich mucin: a potential role in governing the barrier and lubricating functions of intestinal mucus. , 2012, Biomacromolecules.

[203]  M. Johansson,et al.  Preservation of mucus in histological sections, immunostaining of mucins in fixed tissue, and localization of bacteria with FISH. , 2012, Methods in molecular biology.

[204]  B. Warren,et al.  A sweet coating--how bacteria deal with sugars. , 2003, Advances in experimental medicine and biology.

[205]  C. Cordon-Cardo,et al.  Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group‐related antigens , 1997, International journal of cancer.

[206]  H. Gaskins,et al.  On the Relationship between Sialomucin and Sulfomucin Expression and Hydrogenotrophic Microbes in the Human Colonic Mucosa , 2011, PloS one.

[207]  G. Hansson,et al.  Role of mucus layers in gut infection and inflammation. , 2012, Current opinion in microbiology.

[208]  M. Johansson,et al.  An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants , 2012 .

[209]  T. Terada,et al.  EXPRESSION OF MUC APOMUCINS IN NORMAL PANCREAS AND PANCREATIC TUMOURS , 1996, The Journal of pathology.

[210]  A. Darzi,et al.  Gut microbiome-host interactions in health and disease , 2011, Genome Medicine.

[211]  G. Thomas,et al.  Sialic acid utilization by bacterial pathogens. , 2007, Microbiology.

[212]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[213]  C. Reis,et al.  Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma , 2002, Virchows Archiv.

[214]  J. Kihlberg,et al.  Chemoenzymatic Synthesis of Sialylated Glycopeptides Derived from Mucins and T-Cell Stimulating Peptides , 2002 .

[215]  M. Sobrinho-Simões,et al.  Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6) , 2000, The Journal of pathology.

[216]  T. Gerken,et al.  Mucin Glycoprotein Degradation by Mucin Oligosaccharide-degrading Strains of Human Faecal Bacteria. Characterisation of Saccharide Cleavage Products and their Potential Role in Nutritional Support of Larger Faecal Bacterial Populations , 1992 .

[217]  M. Monden,et al.  Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas. , 1999, Journal of experimental & clinical cancer research : CR.

[218]  Henrik Clausen,et al.  Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family. , 2012, Biochimica et biophysica acta.

[219]  S. Hakomori,et al.  Lewisx- and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonic tissues. , 1986, Cancer research.

[220]  Gunnar C. Hansson,et al.  The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions , 2010, Proceedings of the National Academy of Sciences.

[221]  S. Gendler,et al.  Regulation of mucin genes in chronic inflammatory airway diseases. , 2006, American journal of respiratory cell and molecular biology.

[222]  J. van den Born,et al.  Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2. , 2003, Glycobiology.

[223]  B. Warren,et al.  Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: Immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide , 2001, Glycoconjugate Journal.

[224]  J F Vliegenthart,et al.  New type of linkage between a carbohydrate and a protein: C-glycosylation of a specific tryptophan residue in human RNase Us. , 1994, Biochemistry.

[225]  K. Aoki,et al.  Targeted glycoproteomic identification of biomarkers for human breast carcinoma. , 2008, Journal of proteome research.

[226]  S. Bordenstein,et al.  Mom Knows Best: The Universality of Maternal Microbial Transmission , 2013, PLoS biology.

[227]  M. Hollingsworth,et al.  Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis , 2013, International journal of cancer.

[228]  S. Olofsson,et al.  Dimerization of the Human MUC2 Mucin in the Endoplasmic Reticulum Is Followed by a N-Glycosylation-dependent Transfer of the Mono- and Dimers to the Golgi Apparatus* , 1998, The Journal of Biological Chemistry.

[229]  R. Sear,et al.  Adhesion of microorganisms to bovine submaxillary mucin coatings: effect of coating deposition conditions , 2010, Biofouling.

[230]  Michael J. Miller,et al.  Lactobacillus Adhesion to Mucus , 2011, Nutrients.

[231]  Lawrence A Tabak,et al.  Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. , 2012, Glycobiology.

[232]  P. Roussel,et al.  Heterogeneite des chaines glycanniques des mucines bronchiques acides isolees a partir de l'expectoration de deux sujets atteints de bronchite chronique. , 1977 .

[233]  J. Gum,et al.  The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells. , 2003, The Biochemical journal.

[234]  P. Verdugo Goblet cells secretion and mucogenesis. , 1990, Annual review of physiology.

[235]  Walsh,et al.  Prognostic significance of MUC1 epithelial mucin expression in breast cancer. , 1995, Human pathology.

[236]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[237]  J. Taylor‐Papadimitriou,et al.  MUC1 and the Immunobiology of Cancer , 2002, Journal of mammary gland biology and neoplasia.

[238]  Philip Sutton,et al.  Mucin dynamics and enteric pathogens , 2011, Nature Reviews Microbiology.

[239]  D. Thornton,et al.  Identification of Two Glycoforms of the MUC5B Mucin in Human Respiratory Mucus , 1997, The Journal of Biological Chemistry.

[240]  Pedro Verdugo,et al.  Supramolecular dynamics of mucus. , 2012, Cold Spring Harbor perspectives in medicine.

[241]  I. Gipson,et al.  Character of ocular surface mucins and their alteration in dry eye disease. , 2004, The ocular surface.

[242]  J. Dekker,et al.  Role of mucins in inflammatory bowel disease: important lessons from experimental models , 2002, European journal of gastroenterology & hepatology.

[243]  P. Schlag,et al.  Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation , 1997, Virchows Archiv.

[244]  J. Faith,et al.  Predicting a Human Gut Microbiota’s Response to Diet in Gnotobiotic Mice , 2011, Science.

[245]  A. Poustka,et al.  DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. , 2000, Cancer research.

[246]  B. Johansson,et al.  Calcium and pH-dependent packing and release of the gel-forming MUC2 mucin , 2012, Proceedings of the National Academy of Sciences.

[247]  H. Flint,et al.  Microbial degradation of complex carbohydrates in the gut , 2012, Gut microbes.

[248]  J. Gordon,et al.  Coordinate Regulation of Glycan Degradation and Polysaccharide Capsule Biosynthesis by a Prominent Human Gut Symbiont , 2009, The Journal of Biological Chemistry.

[249]  F. Bäckhed Programming of Host Metabolism by the Gut Microbiota , 2011, Annals of Nutrition and Metabolism.

[250]  P. Humbert,et al.  [Heterogeneity of carbohydrate chains of acidic bronchial mucin isolated from the spatum of two subjects with chronic bronchitis]. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[251]  G. Niehans,et al.  Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps , 1999, International journal of cancer.

[252]  S. Batra,et al.  Characterization of Human Mucin MUC17 , 2006, Journal of Biological Chemistry.

[253]  A. Hölscher,et al.  Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence. , 2002, Histology and histopathology.

[254]  K. Foster,et al.  The Evolution of Mutualism in Gut Microbiota Via Host Epithelial Selection , 2012, PLoS biology.

[255]  Bernard Henrissat,et al.  Effects of Diet on Resource Utilization by a Model Human Gut Microbiota Containing Bacteroides cellulosilyticus WH2, a Symbiont with an Extensive Glycobiome , 2013, PLoS biology.

[256]  M. Sakamoto,et al.  Mucosa‐associated bacteria in ulcerative colitis before and after antibiotic combination therapy , 2005, Alimentary pharmacology & therapeutics.

[257]  E. Bloemena,et al.  Distinct localization of MUC5B glycoforms in the human salivary glands. , 2003, Glycobiology.

[258]  H. Jonsson,et al.  A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres to mucus components. , 2002, Microbiology.

[259]  J. Clemente,et al.  The Long-Term Stability of the Human Gut Microbiota , 2013 .

[260]  Richard D Cummings,et al.  Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. , 2005, Glycobiology.

[261]  Y. Chung,et al.  Lex and Ley antigen expression in human pancreatic cancer. , 1988, Cancer research.

[262]  P. Quinton,et al.  A new role for bicarbonate in mucus formation. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[263]  D. Vestweber,et al.  Biochemical Characterization and Molecular Cloning of a Novel Endothelial-Specific Sialomucin , 1999 .

[264]  P. Lantéri,et al.  Mucoadhesion evaluation of polysaccharide gels for vaginal application by using rheological and indentation measurements. , 2012, Colloids and surfaces. B, Biointerfaces.

[265]  J. Rhodes,et al.  Bacteria in the pathogenesis of inflammatory bowel disease , 2006, Current opinion in infectious diseases.

[266]  J. Gordon,et al.  IgA response to symbiotic bacteria as a mediator of gut homeostasis. , 2007, Cell host & microbe.

[267]  P. Rudd,et al.  Divergent Mechanisms of Interaction of Helicobacter pylori and Campylobacter jejuni with Mucus and Mucins , 2013, Infection and Immunity.

[268]  M. Johansson,et al.  Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype , 2012, The Journal of experimental medicine.

[269]  S. Hakomori,et al.  Tumor-associated carbohydrate antigens. , 1984, Annual review of immunology.

[270]  Alison S. Waller,et al.  Genomic variation landscape of the human gut microbiome , 2012, Nature.

[271]  J. Gordon,et al.  How host-microbial interactions shape the nutrient environment of the mammalian intestine. , 2002, Annual review of nutrition.

[272]  F. Hanisch,et al.  Human Tumor Antigen MUC1 Is Chemotactic for Immature Dendritic Cells and Elicits Maturation but Does Not Promote Th1 Type Immunity 1 , 2005, The Journal of Immunology.

[273]  C. Blobel,et al.  Tumor Necrosis Factor-α Converting Enzyme/ADAM 17 Mediates MUC1 Shedding* , 2003, The Journal of Biological Chemistry.

[274]  U. Sommer,et al.  The Terminal Enzymes of Sialic Acid Metabolism: Acylneuraminate Pyruvate-Lyases , 1999, Bioscience reports.

[275]  A. Varki,et al.  Evolutionary considerations in relating oligosaccharide diversity to biological function. , 1999, Glycobiology.

[276]  A. M. Roberton,et al.  Bacterial glycosulphatases and sulphomucin degradation. , 1997, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[277]  Sylvain Julien,et al.  Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis , 2011, Breast Cancer Research.

[278]  Denny G. A. Johansson,et al.  Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin , 2006, Nature Structural &Molecular Biology.

[279]  B. Deplancke,et al.  Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. , 2001, The American journal of clinical nutrition.

[280]  A. Bernkop‐Schnürch,et al.  Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. , 2009, Journal of pharmaceutical sciences.

[281]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[282]  M. Glick,et al.  Terminal glycosylation of cystic fibrosis airway epithelial cells , 2004, Glycoconjugate Journal.

[283]  J. Michalski,et al.  Evidence of Regio-specific Glycosylation in Human Intestinal Mucins , 2003, Journal of Biological Chemistry.

[284]  E. Tian,et al.  Recent insights into the biological roles of mucin-type O-glycosylation , 2009, Glycoconjugate Journal.

[285]  B. Hendry,et al.  Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. , 2004, Carbohydrate research.

[286]  M. Hollingsworth,et al.  Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. , 2010, Cancer research.

[287]  C. Blobel,et al.  Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. , 2003, The Journal of biological chemistry.

[288]  A. Corfield,et al.  Management of the human mucosal defensive barrier: evidence for glycan legislation , 2009, Biological chemistry.

[289]  Lucie Geurts,et al.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.

[290]  S. Baldus,et al.  Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia. , 2000, Advances in cancer research.

[291]  J. Peipert,et al.  Hydrolysis of Secreted Sialoglycoprotein Immunoglobulin A (IgA) in ex Vivo and Biochemical Models of Bacterial Vaginosis* , 2011, The Journal of Biological Chemistry.

[292]  O. Weisz,et al.  Glycosylation differences between a cystic fibrosis and rescued airway cell line are not CFTR dependent. , 1997, The American journal of physiology.

[293]  J. Bara,et al.  Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene , 1998, International journal of cancer.

[294]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[295]  Eric C. Martens,et al.  Complex Glycan Catabolism by the Human Gut Microbiota: The Bacteroidetes Sus-like Paradigm , 2009, The Journal of Biological Chemistry.

[296]  E. Vimr,et al.  Biosynthesis of the Escherichia coli K1 group 2 polysialic acid capsule occurs within a protected cytoplasmic compartment , 2008, Molecular microbiology.

[297]  E. Dabelsteen,et al.  Expression of blood group‐related carbohydrate antigens in normal human pancreatic tissue , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[298]  M. Wolfert,et al.  Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine , 2011, Proceedings of the National Academy of Sciences.

[299]  Jong-Duk Kim,et al.  Mucoadhesive interaction of cysteine grafted poly(2-hydroxyethyl aspartamide) with pig mucin layer of surface plasmon resonance biosensor , 2009 .

[300]  G. Sutherland,et al.  MUC13, a Novel Human Cell Surface Mucin Expressed by Epithelial and Hemopoietic Cells* , 2001, The Journal of Biological Chemistry.

[301]  J. Esko,et al.  The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.

[302]  Y. Chung,et al.  Alterations of O-glycan biosynthesis in human colon cancer tissues. , 1994, Glycobiology.

[303]  J. Voynow,et al.  Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.

[304]  M. Johansson,et al.  Analysis of assembly of secreted mucins. , 2012, Methods in molecular biology.

[305]  C. Hanski,et al.  Sialyl Lewisx Antigen as Defined by Monoclonal Antibody AM-3 Is a Marker of Dysplasia in the Colonic Adenoma-Carcinoma Sequence , 1992 .

[306]  J. Yudkin Human Nutrition , 1961, Nature.

[307]  P. Sutton Helicobacter pylori vaccines and mechanisms of effective immunity: Is mucus the key? , 2001, Immunology and cell biology.

[308]  R. Cummings,et al.  Glycosylation effects on cancer development , 2012, Glycoconjugate Journal.

[309]  Lu-Gang Yu The oncofetal Thomsen–Friedenreich carbohydrate antigen in cancer progression , 2007, Glycoconjugate Journal.

[310]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[311]  J. Gratama,et al.  Cancer specific Mucin‐1 glycoforms are expressed on multiple myeloma , 2006, British journal of haematology.

[312]  A. Macpherson,et al.  Immune adaptations that maintain homeostasis with the intestinal microbiota , 2010, Nature Reviews Immunology.

[313]  S. Baldus,et al.  Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma , 2010, Proteomics.

[314]  E. Verdú Editorial: Differences in Intestinal Microbial Composition in Children With IBS—What Does It All Mean? , 2012, The American Journal of Gastroenterology.

[315]  I. Gipson Human endocervical mucins. , 2005, Ernst Schering Research Foundation workshop.

[316]  O. Blixt,et al.  Random glycopeptide bead libraries for seromic biomarker discovery. , 2010, Journal of proteome research.

[317]  D. Lombardo,et al.  Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. , 1998, Glycobiology.

[318]  R. Poulsom,et al.  Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa , 2000, Gut.

[319]  U. Krengel,et al.  Function of the CysD domain of the gel-forming MUC2 mucin , 2011, The Biochemical journal.

[320]  J. Riordan,et al.  The C-terminus of the transmembrane mucin MUC17 binds to the scaffold protein PDZK1 that stably localizes it to the enterocyte apical membrane in the small intestine. , 2008, The Biochemical journal.

[321]  T. Okai,et al.  Expression of Various Sialylated Carbohydrate Antigens in Malignant and Nonmalignant Pancreatic Tissues , 1991, Pancreas.

[322]  R. Meadows Gut Bacteria May Override Genetic Protections against Diabetes , 2011, PLoS Biology.

[323]  Y. Hiraoka,et al.  Identification of human endomucin‐1 and ‐2 as membrane‐bound O‐sialoglycoproteins with anti‐adhesive activity 1 , 2001, FEBS letters.

[324]  M. Hollingsworth,et al.  Substrate Specificities of Three Members of the Human UDP-N-Acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase Family, GalNAc-T1, -T2, and -T3* , 1997, The Journal of Biological Chemistry.

[325]  H. Sinn,et al.  Analysis of the lewisx epitope in human pancreas and pancreatic adenocarcinomas , 1992, International journal of pancreatology : official journal of the International Association of Pancreatology.

[326]  Pauline M. Rudd,et al.  Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms. , 2011, Journal of proteome research.

[327]  Nicole Tegtmeyer,et al.  The Interaction of Helicobacter pylori with the Adherent Mucus Gel Layer Secreted by Polarized HT29-MTX-E12 Cells , 2012, PloS one.

[328]  M. Johansson,et al.  Perspectives on mucus properties and formation--lessons from the biochemical world. , 2012, Cold Spring Harbor perspectives in medicine.

[329]  C. W. Davis,et al.  CFTR, mucins, and mucus obstruction in cystic fibrosis. , 2012, Cold Spring Harbor perspectives in medicine.

[330]  A. Varki,et al.  Diversity in cell surface sialic acid presentations: implications for biology and disease , 2007, Laboratory Investigation.

[331]  J. Gordon,et al.  Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[332]  A. Dick,et al.  Normal but not altered mucins activate neutrophils , 2004, Cell and Tissue Research.

[333]  M. Johansson,et al.  Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[334]  N. Packer,et al.  Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product. , 1999, Glycobiology.

[335]  A. Thathiah,et al.  MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17. , 2004, The Biochemical journal.

[336]  I. van Seuningen,et al.  Influence of TNFα on the sialylation of mucins produced by a transformed cell line MM-39 derived from human tracheal gland cells , 2001, Glycoconjugate Journal.

[337]  H. Stein,et al.  Detection of a mucin marker for the adenoma-carcinoma sequence inhuman colonic mucosa by monoclonal antibody AM-3. , 1990, Journal of clinical pathology.

[338]  J. Lafitte,et al.  Tumor Necrosis Factor α Increases the Expression of Glycosyltransferases and Sulfotransferases Responsible for the Biosynthesis of Sialylated and/or Sulfated Lewis x Epitopes in the Human Bronchial Mucosa* , 2002, The Journal of Biological Chemistry.

[339]  I. Brockhausen,et al.  Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions , 2006, EMBO reports.

[340]  M. Johansson,et al.  Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[341]  J. Gum,et al.  The N Terminus of the MUC2 Mucin Forms Trimers That Are Held Together within a Trypsin-resistant Core Fragment* , 2002, The Journal of Biological Chemistry.

[342]  D. Relman,et al.  An ecological and evolutionary perspective on human–microbe mutualism and disease , 2007, Nature.

[343]  S. Baldus,et al.  MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology , 2004, Critical reviews in clinical laboratory sciences.

[344]  M. Blaser,et al.  The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.

[345]  J. Dekker,et al.  The MUC5AC Glycoprotein is the Primary Receptor for Helicobacter pylori in the Human Stomach , 2003, Helicobacter.

[346]  I. Brockhausen,et al.  Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells. , 2003, Advances in experimental medicine and biology.

[347]  Roland Schauer,et al.  Sialic acids as regulators of molecular and cellular interactions , 2009, Current Opinion in Structural Biology.

[348]  J. Taylor‐Papadimitriou,et al.  Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation , 2012, Journal of cellular and molecular medicine.

[349]  D. Rogers,et al.  Proteomic analysis of polymeric salivary mucins: no evidence for MUC19 in human saliva. , 2008, The Biochemical journal.